Skip to main content

D. E. Shaw & Co., Inc.

Position in FLGT — Fulgent Genetics, Inc.

CIK 1009207 New York, NY

Position in FLGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,991,963
-$1,747,680 QoQ
Shares Held
292,006
-40.0% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 142 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Derivatives in FLGT

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
0
PutValue
$1,872,300
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,165,536,060 across 26 Diagnostics & Research names. FLGT ranks #19 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLGT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,991,963 292,006
2026-03-31 $7,739,643 486,770
2025-12-31 $18,423,282 701,305
2025-09-30 $12,831,602 567,770
2025-06-30 $9,472,581 476,488
2025-03-31 $7,436,269 440,016
2024-12-31 $2,413,733 130,684
2024-09-30 $1,235,154 56,841
2024-06-30 $2,596,589 132,344
2024-03-31 $2,927,937 134,928
2023-12-31 $1,176,492 40,695
2023-09-30 $1,156,317 43,243
2023-06-30 $1,651,278 44,593
2023-03-31 $2,466,130 78,992
2022-12-31 $1,086,850 36,496
2022-09-30 $1,009,036 26,470
2022-06-30 $1,123,318 20,600
2022-03-31 $1,872,300 30,000
2022-03-31 $730,197 11,700
2021-03-31 $1,942,062 20,100
2021-03-31 $570,541 5,905
2021-03-31 $1,932,400 20,000